ClinicalTrials.gg
Sign In

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Staidson (Beijing) Biopharmaceuticals Co., Ltd clinical trials

Part of Yizhao (Beijing) Medical Science & Technology Co., Ltd., which holds 36.11% as of 2024-12-20. Source

The registry lists 29 studies whose lead sponsor is Staidson (Beijing) Biopharmaceuticals Co., Ltd or one of 1 company grouped under it. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 22, 2026.

Keep track of what changes. Save the Staidson (Beijing) Biopharmaceuticals Co., Ltd studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed
19
Terminated
5
Recruiting
4
Not yet recruiting
1

Phase

Phase 1
19
Phase 2
12
Phase 3
3

Where

China
26
United States
3
Indonesia
1
Bangladesh
1
India
1
Spain
1

Registry sponsor names on this page

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Staidson (Beijing) Biopharmaceuticals Co., Ltd.

  • Staidson (Beijing) Biopharmaceuticals Co., Ltd
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    28 studies
  • Staidson Biopharma Inc.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Studies

Recruiting first, then most recently updated. Showing 29 of 29.